Assertio Therapeutics, Inc.

Sr. Director, Commercial Strategy, Specialty Business Unit

Northern Chicago, IL, United States
Apr 12, 2018
Required Education
Bachelors Degree
Position Type
Full time
The Sr. Director Commercial Strategy-Specialty Business Unit will be on the staff of the SVP of Marketing/GM Specialty Business Unit and will lead the commercial strategy of all products in the Unit This role will report directly to the GM.

• Lead commercial strategy for all products within the Specialty Business Unit.
• Work closely with the CEO, GM and BD to access new assets and play a highly visible role in BD capability presentations and closing deals.
• Develop the Cosyntropin commercial and development plan.
• Partner cross-functionally with key functional leads (i.e. Sales, Marketing, Medical Affairs and Managed Care) to identify and address the full scope of product needs/opportunities.
• Develop and roll out a commercial capabilities presentation and other presentation materials for internal and external audiences (Investor Relations updates, Board of Directors meetings).
• Participate as a member of the corporate executive strategy team.


• BA/BS degree required. MBA preferred. 10 plus years business experience, preferably in the biopharmaceutical or life sciences industry.
• Experience working in orphan or specialty pharmaceutical markets-CNS expertise preferred.
• P&L responsibility
• U.S. expertise-International experience a plus
• Extensive Sales and Marketing experience with a strong understanding of the evolving managed care market.
• Strong analytical skills Excellent communication, organization and analytical skills are required
• Ability to interact effectively across various departments within the company
• Proven teamwork and collaboration skills.

• Integrity
• Decisions & Judgment
• Ownership & Initiative
• Adaptability & Change Readiness
• Teamwork & Collaboration

• Sitting
• Standing/ walking
• Repetitive motion
• Visual Requirements

About Us


Depomed is a leading specialty pharmaceutical company committed to putting the Patient First in everything we do; with a focus on enhancing the lives of patients, families, physicians, providers and in payors through commercialization of products in the areas of pain and neurology, and developing drugs in areas of unmet medical needs.

Depomed currently markets three medicines focused on neuropathic pain and migraine through its Neurology and Pain Business and has an emerging Specialty Business focused on orphan drug indications and areas of unmet medical need.

Depomed has a clear THREE PILLAR strategy for growth:
MAINTAIN a strong/profitable NUCYNTA franchise through a commercialization agreement with Collegium, GROW the Neurology and Pain Business and BUILD a new Specialty Business through a recent Cosyntropin transaction. The company's strategy is to continue to identify, license and develop new products-that offer enhanced therapeutic options to patient populations that may be underserved by existing therapies.

As part of the transformation strategy, Depomed will be relocating its headquarters to northern Chicago, Illinois. Additional information about location will be shared during the interview process.

Depomed is an AA/EEO/Veterans/Disabled employer